The Ventilation During In-hospital Cardiac Arrest Study
Launched by UNIVERSITY OF AARHUS · Jan 29, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Ventilation During In-hospital Cardiac Arrest Study is a research project aimed at understanding how the way we help patients breathe during cardiopulmonary resuscitation (CPR) can affect their chances of surviving a cardiac arrest that happens in the hospital. Specifically, the study is looking at how different amounts of air given during CPR and the speed at which it is given relate to the likelihood of a patient regaining their heart's normal rhythm and circulation. By comparing these different ventilation methods, researchers hope to find out which approach might lead to better survival outcomes for patients.
To be part of this study, participants must be adults aged 18 or older who have experienced a cardiac arrest while in the hospital. They should also have less than one minute of recorded breathing assistance data during the event. Unfortunately, individuals who have a do-not-resuscitate order or who are already receiving certain types of advanced heart support cannot participate. If someone joins the study, they can expect that researchers will closely observe how the ventilation techniques used during their CPR relate to their recovery and overall health after the incident. This research is currently looking for participants, and all genders are welcome to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. In-hospital cardiac arrest
- • 2. Age ≥ 18 years
- • 3. \>1minute of recorded ventilation data
- Exclusion Criteria:
- • 1. Documented do-not-attempt cardiopulmonary resuscitation order
- • 2. Invasive mechanical circulatory support at the time of the cardiac arrest
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, , Denmark
Aalborg, , Denmark
Horsens, , Denmark
Randers, , Denmark
Viborg, , Denmark
Gødstrup, , Denmark
Gødstrup, , Denmark
Patients applied
Trial Officials
Johannes Wittig, MD
Principal Investigator
Department of Clinical Medicine, Aarhus University, Denmark; Department of Medicine, Randers Regional Hospital, Randers, Denmark; Research Center for Emergency Medicine, Aarhus University Hospital, Denmark
Kasper G Lauridsen, MD, PhD
Principal Investigator
Department of Clinical Medicine, Aarhus University, Denmark; Department of Medicine, Randers Regional Hospital, Randers, Denmark; Research Center for Emergency Medicine, Aarhus University Hospital, Denmark;
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported